BOSTON, MA / ACCESSWIRE / October 5, 2022 / Myomo, Inc. (NYSE American:MYO) (“Myomo” or the “Firm”), a wearable medical robotics firm that gives elevated performance for these affected by neurological issues and upper-limb paralysis, at this time introduced that Paul Gudonis, Myomo’s chairman and chief govt officer, will current on the Microcap Rodeo presents The Windy Metropolis Roundup 2022 convention, which is being held stay, in-person on October twelfth – thirteenth, 2022.
Mr. Gudonis is scheduled to current on October 12 at 9:30 a.m. Central time. Administration might be obtainable for one-on-one conferences to be held all through the convention. The presentation might be webcast stay and obtainable for replay right here. The hyperlink additionally might be posted within the Investor’s part of Myomo’s web site.
In regards to the MicroCap Rodeo Finest Concepts Conferences The second-annual, stay in-person MicroCap Rodeo is again. Be part of us as we go on the highway and take part within the Windy Metropolis Roundup 2022 in Chicago, Illinois. Over two days in October, traders can harness high shares for his or her portfolios. They’re going to meet with govt administration groups from roughly 60-plus microcap firms throughout all kinds of industries and achieve an understanding into the important thing worth drivers and potential developments for 2023. Complementing the interactive, in-depth 25-minute one-on-one assembly format might be 4 tracks of firm displays.
About Myomo, Inc.
Myomo, Inc. is a wearable medical robotics firm that gives improved arm and hand operate for these affected by neurological issues and higher limb paralysis. Myomo develops and markets the MyoPro product line. MyoPro is a powered higher limb orthosis designed to assist the arm and restore operate to the weakened or paralyzed arms of sufferers affected by CVA stroke, brachial plexus injury, traumatic mind or spinal cord injury, ALS or different neuromuscular illness or injury. It’s at present the one marketed gadget that, sensing a affected person’s personal EMG alerts by non-invasive sensors on the arm, can restore a person’s skill to carry out actions of day by day residing, together with feeding themselves, carrying objects and doing family duties. Many are in a position to return to work, stay independently and cut back their value of care. Myomo is headquartered in Boston, Massachusetts, with gross sales and scientific professionals throughout the U.S and representatives internationally. For extra info, please go to www.myomo.com.
For Myomo: firstname.lastname@example.org
LHA Investor Relations
Kim Sutton Golodetz 212-838-3777 email@example.com